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Strengths and limitations of this study
 ► Large cohort of patients diagnosed with iron de-
ficiency anaemia (IDA) with exclusion of patients 
known with anaemia 2 years previously.
 ► Long period of follow- up concerning survival and the 
most relevant outcome, namely IDA- related hospital 
diagnoses.
 ► Limited information concerning IDA- related diagno-
ses made out- of- hospital.
 ► Number of events (colorectal cancer) limits the sur-
vival analysis of (late) colorectal cancer.
AbStrACt
Objectives To describe all iron deficiency anaemia 
(IDA)–related causes during follow- up of patients newly 
diagnosed with IDA and to assess whether a delayed 
colorectal cancer (CRC) diagnosis influences survival.
Design and setting Retrospective cohort study of 
patients from general practices in the Dordrecht area, the 
Netherlands.
Participants Men and women aged ≥50 years with a new 
diagnosis of IDA (ie, no anaemia 2 years previously).
Method From February 2007 to February 2018, all 
relevant data were collected from the files of the 
referral hospital. Early IDA- related cause was defined 
as established within 18 weeks after IDA diagnosis. Cox 
proportional- hazards regression was used to analyse 
survival of patients with CRC diagnosis.
results 587 patients with IDA were included with a 
median follow- up of 4.6 years. Early and late IDA- related 
causes could be established in 32% and 8% of patients, 
respectively. Early and late CRC was found in 8% and 
2% of patients, respectively, and were located mainly 
right sided. After adjustment for age, gender and TNM 
classification, mortality risk was lower in patients with IDA 
with early CRC diagnosis, but not significantly (HR 0.30, 
95% CI 0.09 to 1.02).
Conclusion Even with extended follow- up, the cause of 
IDA remains elusive in the majority of patients with IDA 
in general practice. However, patients with IDA are at 
increased risk for in particular right- sided CRC and a late 
diagnosis of CRC appears to have a detrimental effect on 
survival in patients with IDA.
IntrODuCtIOn
Around 5%–10% of patients with iron defi-
ciency anaemia (IDA) have colorectal cancer 
(CRC) and, therefore, endoscopic evalu-
ation is advised.1–5 However, most studies 
reporting on IDA and CRC only included 
patients already referred for endoscopic 
evaluation. Information on general prac-
tice patients diagnosed with IDA and not 
referred for endoscopic evaluation is scarce. 
So far, only two cohort studies have included 
patients from the moment of IDA diagnosis 
in general practice.6 7 These studies reported 
that a third of patients with IDA diagnosed 
in general practice receive an endoscopic 
evaluation within several weeks after IDA 
diagnosis. Of these patients with IDA, the 
incidence of CRC was 4.6% and 5.9%, respec-
tively.6 7 During follow- up of patients with IDA, 
including those who were not endoscopically 
evaluated, an additional 3.2% (follow- up of 
3 years) and 2.4% (follow- up of 1 year) of 
patients were diagnosed with CRC.6 7 Limited 
data are available for the group of patients 
who do not receive an endoscopic evalua-
tion and for whom other underlying causes 
related to IDA might be diagnosed later on. 
Furthermore, it is unknown whether the 3% 
of general practice patients with IDA who 
have a delayed CRC diagnosis have a poorer 
overall survival.
This study investigated a cohort of general 
practice patients with a new laboratory 
diagnosis of IDA. For the entire cohort, 
all IDA- related diagnoses made in- hospital 
are described during extended follow- up. 
Furthermore, we analysed the characteris-
tics of patients with a CRC diagnosis, and the 
association between a delayed CRC diagnosis 
and overall survival.
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MethOD
Patient and public involvement
This study has been retrospectively conducted in a cohort 
of patients formed by general practitioners (GPs) partici-
pating in a large project on anaemia evaluation improve-
ment.8 Therefore, the patients’ involvement has been 
limited. Patients were informed about this project by their 
treating GP. Data about these patients were processed 
anonymously. The participating GPs were informed about 
the study results and encouraged to give feedback.
Study population
The laboratory system of the Albert Schweitzer Hospital 
started a project to improve anaemia evaluation in 
general practice on 1 February 2007, in which 81 of the 
invited 150 GPs (in the Dordrecht area, the Netherlands) 
agreed to participate. Every time the participating GPs 
requested a blood test for their patients aged ≥50 years 
and this revealed a low haemoglobin concentration, a 
comprehensive laboratory assessment was performed. 
This laboratory protocol consisted of measurement 
of haemoglobin, mean corpuscular volume (MCV), C 
reactive protein and/or erythrocyte sedimentation rate, 
vitamin B12, creatinine, ferritin, folic acid, lactate dehy-
drogenase, transferrin, reticulocytes, leucocytes, throm-
bocytes and serum iron.
IDA was defined as haemoglobin <13.7 g/dL for men 
and <12.1 g/dL for women in combination with ferritin 
<25 µg/L for men and <20 µg/L for women.9 The partic-
ipating GPs were provided with the laboratory results for 
each patient, including an interpretation of the labora-
tory diagnosis of IDA, and they were advised to request 
endoscopic evaluation for their patient. Fast- track endo-
scopic evaluation places (ie, within 4 weeks) were avail-
able for these patients.
Retrospectively, we selected a cohort of patients from 
the anaemia improvement project who presented with 
a new laboratory diagnosis of IDA during the period 1 
February 2007 until 1 February 2016 and collected addi-
tional clinical information. We excluded patients who 
were already known with anaemia in the previous 2 years.
Data collection
Clinical data were extracted (if available) from the elec-
tronic medical files of the Albert Schweitzer Hospital. 
Collected clinical information consisted of endoscopic 
evaluations performed within 18 weeks after IDA diag-
nosis and all IDA- related causes established in- hospital 
including the date of the IDA- related diagnosis. Other 
diagnostic investigations to evaluate IDA and/or endo-
scopic evaluations performed 18 weeks after IDA diag-
nosis were not collected. CRC and other IDA- related 
malignancies were checked for registration in the Neth-
erlands Comprehensive Cancer Organization.10 The 
location of CRC was verified using pathology and oper-
ation reports and divided into either right (ie, colon 
ascendens, caecum and transversum) or left (ie, sigmoid, 
colon descendens and rectum). The stage of CRC was 
registered using the TNM 5 classification.11 The length 
of follow- up was variable since patients were selected over 
a 9- year period (2007–2016). The end of follow- up was 
defined as the date of death or the last noted hospital 
record before 1 February 2018 to ensure a follow- up time 
of at least 2 years.
Definitions
Early endoscopic evaluation was defined as all full endos-
copies (ie, gastroscopy and colonoscopy) and colonos-
copies performed within 18 weeks after establishment 
of IDA. Gastroduodenoscopy alone was only counted as 
early endoscopic evaluation if an IDA- related diagnosis 
according to the Dutch anaemia guideline was found.9
Early IDA- related cause was defined as all in- hospital 
registered causes within 18 weeks after the establishment 
of IDA. Late IDA- related cause was defined as all in- hos-
pital registered causes defined 19 weeks or later after the 
establishment of IDA.
The IDA- related causes were divided into four catego-
ries. The first category was defined as all gastrointestinal 
(GI) malignancies and those with a strong suspicion of GI 
malignancy but no pathological proof. The second cate-
gory was defined as other malignancies causing IDA (ie, 
urothelial or endometria carcinoma) and patients with 
a GI metastasis of a non- GI primary tumour. The third 
category was defined as benign GI causes of IDA, which 
included angiodysplasia, gastritis/erosions, ulcers, haem-
orrhoids, polyps ≥1 cm, coeliac disease, Crohn’s disease 
and radiation proctitis. Finally, the fourth category was 
defined as all other non- GI causes of IDA that included 
in- hospital registration of repetitive blood donation, 
hypermenorrhoea, low- iron diet and severe epistaxis as 
cause of IDA.
Statistical analysis
All patients with IDA were divided into either early or no 
(early) endoscopic evaluation and the data were charac-
terised with standard descriptive statistics. Chi- square tests 
and Mann- Whitney U tests were used to compare patients 
receiving endoscopic evaluation and patients without 
endoscopic evaluation. Univariable and multivariable 
logistic regression analysis was performed with CRC diag-
nosis (yes/no) as dependent variable. In these logistic 
regression analyses, the independent variables were age, 
haemoglobin, ferritin, gender (male/female) and MCV 
(microcytic or normocytic/macrocytic anaemia). Inter-
action effects between gender and haemoglobin and 
between gender and ferritin were tested, but not included 
in the final model as they were not statistically significant. 
The goodness- of- fit of the multivariable logistic regres-
sion was assessed using the Hosmer- Lemeshow test. A Cox 
proportional- hazards regression analysis was performed 
including only those patients who received a CRC diag-
nosis during follow- up. In the Cox regression, the time at 
risk was the time from CRC diagnosis until death, or to the 
end of follow- up. In the Cox regression, the independent 
variables were age, gender (male/female), early or late 
4300.7802.430. Protected by copyright.
 o
n
 D
ecem
ber 11, 2019 at Erasm
us M
edical / X51
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2019-032930 on 28 November 2019. Downloaded from 
3Schop A, et al. BMJ Open 2019;9:e032930. doi:10.1136/bmjopen-2019-032930
Open access
Table 1 Baseline characteristics of the 587 patients in general practice with iron deficiency anaemia (IDA)
IDA cohort
n=587 (100%)
Early endoscopic 
evaluation
n=211 (36%)
No early endoscopic 
evaluation
n=376 (64%) P value
Reference 
value
Age in years 68 (50–101) 69 (50–95) 66 (50–101) 0.207
Gender       <0.001
  Male 212 (36%) 100 (47%) 112 (30%)
  Female 375 (64%) 111 (53%) 264 (70%)
Haemoglobin, g/dL       
  Male 12.3 (5.3–13.5) 10.6 (5.3–13.5) 12.8 (5.8–13.5) <0.001 13.7–17.7
  Female 10.8 (4.0–11.9) 10.2 (4.5–11.9) 11.1 (4.0–11.9) <0.001 12.1–16.1
MCV, fL 82 (55–102) 79 (55–96) 83 (58–102) <0.001 82–98
ESR, mm/h* 20 (2–120) 23 (4–118) 20 (2–120) 0.015 <35
C reactive protein, mg/L† <5 (<5–144)   <5 (<5–71) <5 (<5–144) <0.001 <10
Ferritin, µg/L       
  Male 10 (2–24) 9 (2–24) 11 (2–23) <0.001 25–250
  Female 7 (1–19) 7 (1–19) 8 (1–19) 0.055 20–250
Iron saturation, %‡ 7 (2–55) 6 (2–22) 7 (2–55) <0.001 20–60
Serum iron, µmol/L       
  Male 6.2 (1.9–22.1) 4.5 (1.9–22.1) 7.4 (2.0–21.0) <0.001 14–28
  Female 5.0 (1.6–42.5) 3.9 (1.9–17.6) 5.3 (1.6–42.5) 0.001 10–25
Transferrin, g/L 3.36 (1.97–4.74) 3.38 (2.38–4.74) 3.34 (1.97–4.74) 0.043 2.00–3.60
*Missing values n=157.
†Missing values n=3.
‡Missing values n=38. Values are median (range). Measured laboratory values are at point of IDA diagnosis. The p value compares the 
baseline characteristic of patients with and those without an early endoscopic evaluation.
ESR, erythrocyte sedimentation rate; MCV, mean corpuscular volume.
CRC diagnosis, and stage of CRC (I, II, III, IV or unknown 
stage). The proportional- hazards assumption was tested 
by including interactions of independent variables and 
follow- up time in a Cox regression with time- dependent 
covariates. The location of CRC was compared between 
patients with an early or late diagnosis using a χ2 test.
Data were analysed using SPSS for Windows, V.24. All 
statistical tests were two- sided and a p value <0.05 was 
considered statistically significant.
reSultS
Cohort description
Between 1 February 2007 and 1 February 2016, a total 
of 587 patients aged ≥50 years with a new laboratory 
diagnosis of IDA were included, consisting of 212 (36%) 
men and 375 (64%) women. The median haemoglobin 
concentration was 12.3 (range, 5.3–13.5) g/dL and 10.8 
(range, 4.0–11.9) g/dL and the median ferritin level 
was 10 (range, 2–24) µg/L and 7 (range, 1–19) µg/L for 
men and women, respectively. Basic characteristics (age, 
gender and laboratory values at point of IDA diagnosis) 
are presented in table 1.
early endoscopic evaluation
Of all 587 general practice patients diagnosed with IDA, 
211 (36%) had an early endoscopic evaluation, consisting 
of 45 (21%) colonoscopies, 154 (73%) full endoscopies 
and 12 (6%) gastroscopies. The median time for early 
endoscopic evaluation was 5 weeks (IQR 2–7 weeks). 
Patients receiving endoscopic evaluation versus those 
who did not receive early endoscopy were significantly 
different in terms of laboratory values and gender, but 
not in age (table 1). In 115 (55%) of the 211 patients, 
who received an early endoscopic evaluation, a GI- related 
diagnosis could be made.
IDA-related causes
Median time of follow- up for the entire cohort was 4.6 
(IQR 2.6–7.0) years, during which an IDA- related cause 
could be made in 234 (40%) patients, consisting of 190 
(32%) early causes and 44 (8%) late causes. However, 
in 353 patients (60%), no IDA- related cause was found 
during the entire follow- up period (figure 1). In 18 
patients, more than one IDA- related cause was estab-
lished resulting in 254 in- hospital registered causes of 
IDA (table 2). Other causes (34%) and benign GI causes 
(35%) were the most common categories. An early 
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Figure 1 Flowchart of the cohort with iron deficiency 
anaemia (IDA).
malignant cause for IDA was found in 59 patients (10%), 
of whom 49 had CRC. An additional 21 patients (4%), 
of whom four received an early endoscopic evaluation 
without abnormalities, were diagnosed with a malignant 
cause for IDA later on, consisting of 12 CRC.
Colorectal cancer
Of the 587 patients with IDA, 61 (10%) received a diag-
nosis of CRC during the study period (ie, 49 early and 
12 late CRC diagnoses). In four patients, two separate 
tumours were diagnosed in the colon, and one patient 
presented with three different colon tumour locations. 
The CRC was right sided in 41 of 49 patients (84%) with 
an early diagnosis and in 8 of 12 patients (67%) with a 
late CRC diagnosis (p=0.184). Older age (OR 1.03; 95% 
CI 1.00 to 1.05), male gender (OR 2.12; 95% CI 1.18 to 
3.79), lower haemoglobin concentrations (OR 1.27; 95% 
CI 1.08 to 2.49) and microcytic anaemia (OR 2.63; 95% 
CI 1.30 to 5.31) showed a significant association with CRC 
diagnosis (table 3).
The 61 patients with CRC diagnosis had a median 
follow- up of 4 years (range, 5 weeks to 10.7 years) from the 
moment of CRC diagnosis; during this period, 19 patients 
(31%) died. No significant violations of the proportional- 
hazards assumption of the Cox regression were detected 
in patients with CRC diagnosis. After correction for age, 
gender and the TNM classification at the moment of CRC 
diagnosis, mortality risk was lower, but not significant, in 
the group of patients with an early CRC diagnosis (HR 
0.30; 95% CI 0.09 to 1.02) (table 4).
DISCuSSIOn
Principal findings
In this large retrospective cohort study, an early endo-
scopic evaluation was done in a third of newly diagnosed 
patients with IDA, and these patients were more often 
male gender and had more severe laboratory abnor-
malities. The most common category if IDA- related 
causes established in this cohort were benign GI causes 
(35%). However, in the majority of patients (60%), no 
in- hospital IDA- related cause could be found during the 
median follow- up of 4.6 years. In addition, there were 
8% early and 2% late CRC diagnoses. A CRC diagnosis 
was associated with older age, male gender, lower haemo-
globin concentrations and microcytic anaemia. In addi-
tion, some evidence was found for increased survival in 
patients with IDA with an early CRC diagnosis adjusted 
for age, gender and TNM classification, but this associa-
tion was not statistically significant.
Strengths and limitations of this study
Inclusion of patients in our cohort occurred after an 
anaemia diagnosis was established in the laboratory. 
The GPs’ reason for laboratory testing was not known. 
It could have been either specific symptoms in a patient 
or routine testing for other indications. Still, a diagnostic 
work- up should start after an IDA is established according 
to the Dutch GP guideline. This is a well- defined moment 
in practice.
The participating GPs usually referred their patients to 
the associated hospital; however, some patients may have 
preferred referral to a different hospital resulting in an 
underestimation of the amount of endoscopic evalua-
tions and IDA- related causes. However, since almost all 
patients in our cohort had an electronic record in the 
associated hospital, this limits the possibility of missed 
cases. Furthermore, the two nearest hospitals, both 
outside the Dordrecht region, had a longer waiting time 
for endoscopic evaluation compared with the fast- track 
places we offered the participating GPs. The fast- track 
places that were offered to the participating GPs during 
the study period might have led to an increase in early 
endoscopic evaluations and thereby an increased early 
IDA- related diagnoses. However, the rate of early endo-
scopic evaluation was comparable with existing literature 
and therefore the fast- track places very likely did not 
affect the study results.6 7
Another aspect that we were unable to monitor was the 
possibility of consciously refraining from endoscopic eval-
uation by the GP and/or the patient. One study found 
that endoscopic evaluation in patients aged ≥85 years 
is safe and enables a high rate of diagnoses and thera-
peutic modifications.12 Nevertheless, comorbidities, age 
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Table 2 Iron deficiency anaemia (IDA)–related causes
Early endoscopic evaluation No early endoscopic evaluation
TotalEarly cause Late cause Early cause Late cause
GI malignancies 74 (29%)
  Colon 48 1 1* 11
  Gastric 3 1
  Oesophagus 2
  Small bowel 1
  Strong suspicion of GI malignancy 1 1 4
Other malignancies 6 (2%)
  Urothelial 1 1 1
  GI metastasis of a non- GI primary 2 1
  tumour
Other causes† 36 3 43 4 86 (34%)
Benign GI causes 88 (35%)
  Angiodysplasia 16 2 5
  Gastritis/erosions 19 1 4
  Ulcers‡ 10
  Haemorrhoids 4 2
  Polyps >1 cm 13 1 3
  Coeliac/Crohn/ulcerative colitis 4 3
  Radiation proctitis 1
Total no of IDA- related causes 159 11 48 36 254 (100%)
*Diagnosis made on the basis of surgery for colon perforation.
†Other causes included repetitive blood donation, hypermenorrhoea, low- iron diet and severe epistaxis.
‡Including gastric ulcers as a result of Helicobacter pylori infection.
GI, gastrointestinal.
and limited life expectancy may still be reasons to refrain 
from endoscopic evaluation. We did not collect data on 
other diagnostic investigations and/or endoscopic evalu-
ations performed more than 18 weeks after IDA diagnosis. 
However, we did document all IDA- related diagnoses 
made in- hospital during follow- up and some diagnoses, 
especially non- GI related, were made by means of other 
investigations than endoscopic evaluation.
It is important to realise that, in the present study, all 
diagnoses made during follow- up were registered in- hos-
pital. A limitation is that the IDA- related causes found by 
the GP are not registered and, therefore, might be under-
estimated. However, the most relevant IDA- related causes, 
mainly GI- tract related, require in- hospital investigations, 
which makes the incidence of these causes found in our 
cohort reliable. In addition, the most worrying outcome 
is IDA- related malignancy; therefore, we registered these 
diagnoses from the Netherlands Comprehensive Cancer 
Organization. This organisation covers the entire Dutch 
population regarding cancer registrations, and therefore 
this ensures full representation of IDA- related malignan-
cies. Finally, the survival analysis provided some evidence 
for an association between early CRC diagnosis and 
decreased mortality; however, lead- time bias may still be 
present. A more detailed analysis with a larger cohort is 
required to confirm our hypothesis of increased overall 
survival in patients with early CRC diagnosis.
Comparison with existing literature
In the present study, a third of newly diagnosed patients 
with IDA in general practice received early endoscopic 
evaluation; this is in line with others.6 7 Patients with IDA 
receiving early endoscopic evaluation are more often 
men. In the Netherlands, CRC has a higher incidence 
among men compared with women.13 This might have 
stimulated GPs to perform more endoscopies in men. In 
addition, if women presented with hypermenorrhea, GPs 
may not have made an initial endoscopic evaluation or 
a hospital referral. Furthermore, patients with IDA with 
early endoscopic evaluation had more severe laboratory 
abnormalities. Some GPs will have a different policy in 
case of marginal anaemia, that is, these patients might 
first be treated with iron supplementation before GPs 
decide to refer for endoscopic evaluation.
This study shows, for the first time, that a small propor-
tion of the IDA- related causes is made by means of inves-
tigations other than endoscopy. These diagnoses were 
mainly non- GI causes, including blood donation and 
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Table 3 Logistic regression analysis comparing patients with olorectal cancer (CRC) to those without CRC
CRC diagnosis
n=61
No CRC diagnosis
n=526
Univariable analysis Multivariable analysis
OR (95% CI) P value OR (95% CI) P value
Age, median (range) 75 (50–89) 66 (50–101) 1.03 (1.01 to 
1.03)
0.002 1.03 (1.00 to 1.05) 0.027
Gender     
  Male 28 (5%) 184 (31%) Reference group 2.12 (1.18 to 3.79) 0.012
  Female 33 (6%) 342 (58%) 0.63 (0.37 to 
1.08)
0.095 Reference group
Haemoglobin (g/dL)*, 
median (range)
9.3 (4.5–12.9) 11.3 (4.0–13.5) 1.41 (1.23 to 
1.58)
<0.001 1.27 (1.08 to 1.49) 0.007
Ferritin (µg/L)*, median 
(range)
7 (1–22) 9 (1–24) 0.94 (0.89 to 
1.00)
0.052 1.01 (0.93 to 1.09) 0.844
MCV category     
  Normocytic/
macrocytic† (MCV 
80–102 fL)
20 (3%) 349 (60%) Reference group Reference group
  Microcytic (MCV <80 fL) 41 (7%) 177 (30%) 4.04 (2.30 to 
7.11)
<0.001 2.63 (1.30 to 5.31) 0.007
*Analysed as continuous variables. ORs should be interpreted as the effect of 1- unit decrease in concentration for haemoglobin and 1- unit 
increase in concentration of ferritin.
†Three patients had an MCV value >100 fL at the time of IDA diagnosis.
IDA, iron deficiency anaemia; MCV, mean corpuscular volume.
Table 4 Cox proportional- hazards survival analysis for patients diagnosed with colorectal cancer
Deceased
n=19 (31%)
Alive
n=42 (69%)
Univariable analysis
Multivariable analysis
HR (95% CI) P value HR (95% CI) P value
Age, median (range) 78 (50–87) 73 (52–89) 1.06 (1.00 to 1.12) 0.063 1.10 (1.02 to 1.19) 0.017
Gender         
  Male 8 (13%) 20 (33%) 0.77 (0.31 to 1.93) 0.582 1.58 (0.57 to 4.36) 0.377
  Female 11 (18%) 22 (36%) Reference group   Reference group   
Time to diagnosis         
  Early 13 (21%) 36 (59%) 0.32 (0.12 to 0.87) 0.026 0.30 (0.09 to 1.02) 0.053
  Late 6 (10%) 6 (10%) Reference group   Reference group   
TNM stage   0.003   <0.001
  I 1 (2%) 11 (18%) Reference group   Reference group   
  II 3 (5%) 13 (21%) 3.23 (0.32 to 32.97) 0.323 3.47 (0.33 to 36.75) 0.302
  III 5 (8%) 12 (20%) 4.16 (0.48 to 35.97) 0.195 5.35 (0.57 to 49.94) 0.141
  IV 10 (16%) 5 (8%) 24.31 (2.78 to 212.41) 0.004 80.15 (7.47 to 859.67) <0.001
  Unknown – 1 (2%) NA NA NA NA
NA, not applicable.
hypermenorrhoea (despite applying a 50- year cut- off 
to prevent hypermenorrhoea as predominant cause of 
IDA). Most of these IDA- related diagnoses were made in 
the subgroup of patients who received early endoscopic 
evaluation.
The majority of patients who did not receive early 
endoscopic evaluation did not have an IDA- related cause 
defined during the extended follow- up. To our knowl-
edge, this has not been described in detail before.
Although the majority of patients with IDA without 
endoscopic evaluation have no IDA- related diagnosis 
during follow- up, a third of the patients with a late IDA- 
related cause were diagnosed with a GI malignancy, and an 
additional 11% had a strong suspicion of GI malignancy. 
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These diagnoses might represent missed opportunities at 
the time of IDA diagnosis and should alert GPs in their 
aim to unravel the underlying cause of IDA. Based on 
our study results, omitting early endoscopic evaluation in 
patients with IDA is not safe. As also has been described in 
several guidelines before, endoscopic evaluation should 
be performed in all patients aged 50 years and older with 
a new diagnosis of IDA.9 11
We observed 8% of CRC diagnoses within 18 weeks 
of finding IDA in our cohort, whereas 2% of patients 
received this diagnosis during follow- up. Comparison of 
these results with previous data on patients with IDA in 
general practice revealed a slight increase in early diag-
noses and a decrease in delayed diagnoses.6 7 This might 
be due to the comment that was added to the labora-
tory results alerting GPs to an endoscopic evaluation in 
patients with IDA. Furthermore, we offered participating 
GPs fast- track places for endoscopic evaluation, which 
may have led to earlier endoscopic evaluations.
Although the association between early versus late CRC 
diagnosis and mortality was not statistically significant in 
our data, the point estimate and its 95% CI were in line 
with previous studies in which early colonoscopy signifi-
cantly increased overall survival in patients with CRC 
diagnosis.14 15 The estimated association was adjusted 
for the TNM classification of the tumour at the time of 
diagnosis. Apparently, early- stage disease is important for 
better survival rates, and early CRC diagnosis, regardless 
of TNM classification, is too. This might be due to a better 
clinical condition at the moment of CRC diagnosis and 
start of treatment.
Finally, it was observed that in patients with IDA most 
early CRC diagnoses were right sided (84%) possibly 
caused by the absence of GI complaints such as rectal 
bleeding.16 This lack of complaints may allow tumours to 
bleed unnoticed for a longer time, resulting in a diagnosis 
of IDA before the CRC is found. During our study period, 
34% of all CRC diagnoses in the whole Dutch population 
were right sided according to the Netherlands Compre-
hensive Cancer Organization (data not shown).10 Our 
results support the suspicion that right- sided tumours are 
more frequently encountered in patients with IDA.9 16
Implications for clinicians
The majority of patients with IDA in general practice do 
not have an IDA- related cause defined during extended 
follow- up. However, endoscopic evaluation for all patients 
with IDA is justified since these patients are at increased 
risk for, in particular, right- sided CRC. Importantly, 
patients with IDA in general practice with a delayed diag-
nosis of CRC might risk decreased overall survival.
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